CIVO screen for drugs that are synergistic with pancreatic cancer standard of care Abraxane® in a Gemcitabine resistant xenograft model.

v1

CIVO screen for drugs that are synergistic with pancreatic cancer standard of care Abraxane<sup>®</sup> in a Gemcitabine resistant xenograft model.

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/9DF9DA8F.svg?ark=w1%2F20261004%2F9DF9DA8F&value=id)](https://nobleid.org/work/w1/20261004/9DF9DA8F)

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →